Intracellular glutathione regulates tumour necrosis factor-alpha-induced p38 MAP kinase activation and RANTES production by human bronchial epithelial cells

Human Bronchial Epithelial Cells ◽

Necrosis Factor Alpha ◽

Bronchial Epithelial ◽

Kinase Activation ◽

Factor Alpha ◽

Rantes Production ◽

Intracellular glutathione regulates tumour necrosis factor-α-induced p38 MAP kinase activation and RANTES production by human bronchial epithelial cells

Clinical & Experimental Allergy ◽

10.1111/j.1365-2222.2001.00967.x ◽

2001 ◽

Vol 31 (1) ◽

pp. 144-151

Author(s):

S. Hashimoto ◽

Y. Gon ◽

K. Matsumoto ◽

I. Takeshita ◽

T. Machino ◽

...

Keyword(s):

Tumour Necrosis ◽

P38 Map Kinase ◽

Tumour Necrosis Factor Α ◽

Human Bronchial Epithelial Cells ◽

Bronchial Epithelial ◽

Kinase Activation ◽

Intracellular Glutathione ◽

Factor Α ◽

Rantes Production ◽

Tumour necrosis factor-alpha potentiates CR3-induced respiratory burst by activating p38 MAP kinase in human neutrophils

Immunology ◽

10.1046/j.1365-2567.2001.01270.x ◽

2001 ◽

Vol 103 (4) ◽

pp. 465-472 ◽

Cited By ~ 33

Author(s):

Maria Forsberg ◽

Ragnhild Lofgren ◽

Limin Zheng ◽

Olle Stendahl

Keyword(s):

Map Kinase ◽

Tumour Necrosis Factor ◽

Respiratory Burst ◽

Tumour Necrosis ◽

P38 Map Kinase ◽

Human Neutrophils ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Role of interleukin-1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behaviour: a study with interleukin-1 type I receptor-deficient mice

European Journal of Neuroscience ◽

10.1046/j.1460-9568.2000.01348.x ◽

2000 ◽

Vol 12 (12) ◽

pp. 4447-4456 ◽

Cited By ~ 24

Author(s):

Rose-Marie Bluthe ◽

Sophie Laye ◽

Bruno Michaud ◽

Chantal Combe ◽

Robert Dantzer ◽

...

Keyword(s):

Tumour Necrosis ◽

Interleukin 1 ◽

Type I ◽

Sickness Behaviour ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Deficient Mice ◽

P3442 In vivo inhibition of tumour necrosis factor-alpha reverses mitochondrial dysfunction in pacing-induced cardiomyopathy: Insights into role of cytokines and heart failure progression

European Heart Journal ◽

10.1016/s0195-668x(03)96068-4 ◽

2003 ◽

Vol 24 (5) ◽

pp. 665

Author(s):

J MARINGARCIA

Keyword(s):

Heart Failure ◽

Mitochondrial Dysfunction ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Heart Failure Progression ◽

Factor Alpha ◽

Short-term histopathological response to anti-tumour necrosis factor alpha therapy in patients with ulcerative colitis

10.26226/morressier.596dfd59d462b80292387586 ◽

2017 ◽

Author(s):

Diana-Alexandra Costache

Keyword(s):

Ulcerative Colitis ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Short Term ◽

Histopathological Response ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Therapy ◽

Faculty Opinions recommendation of A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6'-dimycolate induced granulomatous response.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120210.576363 ◽

2008 ◽

Author(s):

John Atkinson

Keyword(s):

Tumour Necrosis Factor ◽

Interleukin 6 ◽

Tumour Necrosis ◽

Necrosis Factor Alpha ◽

Cord Factor ◽

Factor Alpha ◽

Necrosis Factor ◽

Granulomatous Response

Faculty Opinions recommendation of Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1162910.623534 ◽

2009 ◽

Author(s):

Ulf Müller-Ladner

Keyword(s):

Tumour Necrosis Factor ◽

Dose Escalation ◽

Inflammatory Arthritis ◽

Tumour Necrosis ◽

Phase 1 ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Alpha Antagonist ◽

Faculty Opinions recommendation of Endemic fungal infections in patients receiving tumour necrosis factor-alpha inhibitor therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2695956.2359056 ◽

2010 ◽

Author(s):

Scott Davies

Keyword(s):

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Fungal Infections ◽

Inhibitor Therapy ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

Faculty Opinions recommendation of Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718325310.793492804 ◽

2014 ◽

Author(s):

Ronald van Vollenhoven

Keyword(s):

Rheumatoid Arthritis ◽

Tumour Necrosis ◽

Active Rheumatoid Arthritis ◽

Methotrexate Therapy ◽

Human Antibody ◽

Necrosis Factor Alpha ◽

Subcutaneous Injections ◽

Factor Alpha ◽

Inflammatory cytokine (interleukin 6 and tumour necrosis factor alpha) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide

Clinical & Experimental Immunology ◽

10.1046/j.1365-2249.2002.01946.x ◽

2002 ◽

Vol 130 (3) ◽

pp. 467-474 ◽

Cited By ~ 19

Author(s):

M. P. JAGGER ◽

Z. HUO ◽

P. G. RICHES

Keyword(s):

Streptococcus Pneumoniae ◽

Tumour Necrosis ◽

Inflammatory Cytokine ◽

Capsular Polysaccharide ◽

Blood System ◽

Necrosis Factor Alpha ◽

Human Whole Blood ◽

Factor Alpha ◽